As both sentinels and effectors of disease response, peripheral blood mononuclear cells are an accessible and attractive target for clinical application of high throughput, fluidics based single cell RNASeq (scRNASeq). However, new analytic tools required by unique characteristics of scRNASeq data lack validation in acutely ill patients. We report scRNASeq analysis of ~1,000 20 cells from each of 38 patients requiring veno-arterial extracorporeal life support (VA-ECLS)-a diverse group of critically ill patients experiencing circulatory collapse as a common endpoint to wide ranging diseases. We established an analysis pipeline capturing major biological signals from theses samples, confirmed by flow cytometry. Further, we found that these patients appeared immunologically poised at the outset of treatment as either reactive or permissive, and 25 this balance predicted their survival. Annotated code detailing the analysis is available at https://github.com/vanandelinstitute/va_ecls.